Flaxseed Benefits: What the Evidence Actually Shows

Flaxseed is one of the few "health foods" whose reputation survives a hard look at the trials. Three things set it apart, and each has its own body of human evidence. It is the richest common plant source of the omega-3 fat alpha-linolenic acid (ALA) — a level tablespoon of ground seed carries about 1.6 g of it. It is, by a very wide margin, the richest food source of lignans, plant compounds that gut bacteria turn into weak, oestrogen-like molecules. And more than a quarter of its weight is fibre, much of it a slippery soluble gum called mucilage. The strongest human results sit on the heart side: a six-month, 110-patient placebo-controlled trial in people with clogged leg arteries found that 30 g of milled flaxseed a day lowered systolic blood pressure by about 10 mmHg, and the same trial found flaxseed lowered LDL cholesterol on top of what statins were already doing. Blood-sugar and bowel benefits are real but smaller and depend on eating the whole ground seed rather than the oil. The lignan-and-cancer story is the most interesting and the least settled: a well-designed pre-surgery trial found flaxseed slowed the growth rate of breast tumours, and another did the same in prostate cancer, but neither measured whether anyone lived longer, and the population studies point the same way without proving cause. The four deep dives below cover each of those threads and finish with the practical questions — ground or whole, seed or oil, the cyanide arithmetic done honestly, and who should be careful.

Deep-Dive Articles

Flaxseed Lignans and Hormone-Related Cancers

What secoisolariciresinol diglucoside is, how gut bacteria turn it into enterolactone, and what that does to hormones. The Toronto pre-surgery trial in which a 25 g flaxseed muffin a day cut breast-tumour proliferation by a third, the 161-man prostate trial that separated flaxseed from fat restriction, the Ontario case-control study and the two meta-analyses of lignans and breast cancer — and the honest limits: no trial has measured survival, and a large seven-cohort pooled analysis found no link between blood lignans and prostate cancer.

Flaxseed ALA Omega-3 and Heart Health

Why ALA is not fish oil: the isotope-tracer studies that measured how little of it becomes EPA and almost none becomes DHA. Then the evidence that ALA matters anyway — the cohort meta-analyses, and the Flax-PAD trial, one of the largest blood-pressure effects ever recorded for a food. The cholesterol meta-analyses (ground seed and lignans work, the oil does not), the statin add-on finding, and the prostate-cancer question that hangs over high ALA intakes, read across three meta-analyses.

Flaxseed Fibre, Constipation and Blood Sugar

Mucilage, the soluble gum that makes soaked flax slippery, and what it does in the gut. The Iranian trials in constipated people with type 2 diabetes where 10 g of flaxseed twice a day beat both placebo and psyllium, the IBS pilot that found nothing, the 30% rise in bowel movements at 50 g a day, and the glucose meta-analyses — a real fall in fasting glucose and insulin resistance with whole seed, and one review where HbA1c did not budge. Includes the finding that 13 g a day worked where 26 g did not.

Ground vs Whole Flaxseed, Flax Oil, Cyanogens and Safety

The bioavailability trials that settle the grinding question — whole seed raised blood ALA not at all and delivered under a third of the lignans. What baking does (surprisingly little), how fast ground seed goes rancid (slower than feared), why the oil is a different food. The cyanogenic glycosides done quantitatively, using a human cross-over study and the EFSA 2019 opinion. Then the real cautions: rare but genuine anaphylaxis, the pregnancy question, medicines and fibre, and why dry seed needs water.

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. What Is Actually In Flaxseed
  3. Key Research Papers: ALA, Blood Pressure and Cholesterol
  4. Key Research Papers: Lignans and Hormone-Related Cancers
  5. Key Research Papers: Fibre, Bowel and Blood Sugar
  6. Key Research Papers: Form, Processing and Safety
  7. External Authoritative Resources
  8. Connections
  9. Featured Videos

What Is Actually In Flaxseed

The figures below are USDA FoodData Central's entry for whole flaxseed (FDC 169414), per 100 g. A level tablespoon of ground flaxseed weighs about 7 g; a tablespoon of whole seed is heavier, about 10 g, because the seeds pack tighter. Multiply accordingly.

Two practical consequences follow. First, the interesting parts of flaxseed are the ALA, the lignans and the mucilage, and all three sit behind a hard seed coat that human teeth and stomach acid do not reliably break. That is why "ground versus whole" is the most important question on these pages, and it has been settled by direct measurement. Second, flaxseed oil is not flaxseed: pressing the oil keeps the ALA and discards the fibre and nearly all the lignans. Trial after trial finds the ground seed does things the oil does not, and the deep dives return to that distinction repeatedly.

Back to Table of Contents

Key Research Papers: ALA, Blood Pressure and Cholesterol

  1. Rodriguez-Leyva D, Weighell W, Edel AL, et al. (2013). Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. — PubMed PMID: 24126178
  2. Edel AL, Rodriguez-Leyva D, Maddaford TG, et al. (2015). Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. The Journal of Nutrition. — PubMed PMID: 25694068
  3. Caligiuri SP, Aukema HM, Ravandi A, Guzman R, Dibrov E, Pierce GN (2014). Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension. — PubMed PMID: 24777981
  4. Khalesi S, Irwin C, Schubert M (2015). Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials. The Journal of Nutrition. — PubMed PMID: 25740909
  5. Ursoniu S, Sahebkar A, Andrica F, Serban C, Banach M (2016). Effects of flaxseed supplements on blood pressure: a systematic review and meta-analysis of controlled clinical trial. Clinical Nutrition. — PubMed PMID: 26071633
  6. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009). Meta-analysis of the effects of flaxseed interventions on blood lipids. The American Journal of Clinical Nutrition. — PubMed PMID: 19515737
  7. Hadi A, Askarpour M, Salamat S, Ghaedi E, Symonds ME, Miraghajani M (2020). Effect of flaxseed supplementation on lipid profile: an updated systematic review and dose-response meta-analysis of sixty-two randomized controlled trials. Pharmacological Research. — PubMed PMID: 31899314
  8. Pan A, Chen M, Chowdhury R, et al. (2012). α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. The American Journal of Clinical Nutrition. — PubMed PMID: 23076616
  9. Naghshi S, Aune D, Beyene J, Mobarak S, Asadi M, Sadeghi O (2021). Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies. BMJ. — PubMed PMID: 34645650
  10. Burdge GC, Wootton SA (2002). Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. The British Journal of Nutrition. — PubMed PMID: 12323090
  11. Bloedon LT, Balikai S, Chittams J, et al. (2008). Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. Journal of the American College of Nutrition. — PubMed PMID: 18460483

Back to Table of Contents

Key Research Papers: Lignans and Hormone-Related Cancers

  1. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE (2005). Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clinical Cancer Research. — PubMed PMID: 15897583
  2. Demark-Wahnefried W, Polascik TJ, George SL, et al. (2008). Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiology, Biomarkers & Prevention. — PubMed PMID: 19064574
  3. Lowcock EC, Cotterchio M, Boucher BA (2013). Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes & Control. — PubMed PMID: 23354422
  4. Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J (2010). Meta-analyses of lignans and enterolignans in relation to breast cancer risk. The American Journal of Clinical Nutrition. — PubMed PMID: 20463043
  5. Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV (2009). Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. British Journal of Cancer. — PubMed PMID: 19337250
  6. Buck K, Vrieling A, Zaineddin AK, et al. (2011). Serum enterolactone and prognosis of postmenopausal breast cancer. Journal of Clinical Oncology. — PubMed PMID: 21900115
  7. McCann SE, Thompson LU, Nie J, et al. (2010). Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Research and Treatment. — PubMed PMID: 20033482
  8. Perez-Cornago A, Appleby PN, Boeing H, et al. (2018). Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls. International Journal of Cancer. — PubMed PMID: 29971774
  9. Pruthi S, Qin R, Terstreip SA, et al. (2012). A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. — PubMed PMID: 21900849
  10. Flower G, Fritz H, Balneaves LG, et al. (2014). Flax and Breast Cancer: A Systematic Review. Integrative Cancer Therapies. — PubMed PMID: 24013641
  11. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006). Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutrition and Cancer. — PubMed PMID: 16898863

Back to Table of Contents

Key Research Papers: Fibre, Bowel and Blood Sugar

  1. Soltanian N, Janghorbani M (2018). A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes. Nutrition & Metabolism. — PubMed PMID: 29760761
  2. Soltanian N, Janghorbani M (2019). Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: a randomized trial in constipated patients with type 2 diabetes. Clinical Nutrition ESPEN. — PubMed PMID: 30661699
  3. Cockerell KM, Watkins AS, Reeves LB, Goddard L, Lomer MC (2012). Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial. Journal of Human Nutrition and Dietetics. — PubMed PMID: 22690855
  4. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins DJ (1995). Nutritional attributes of traditional flaxseed in healthy young adults. The American Journal of Clinical Nutrition. — PubMed PMID: 7825540
  5. Mohammadi-Sartang M, Sohrabi Z, Barati-Boldaji R, Raeisi-Dehkordi H, Mazloom Z (2018). Flaxseed supplementation on glucose control and insulin sensitivity: a systematic review and meta-analysis of 25 randomized, placebo-controlled trials. Nutrition Reviews. — PubMed PMID: 29228348
  6. Villarreal-Renteria AI, Herrera-Echauri DD, Rodríguez-Rocha NP, et al. (2022). Effect of flaxseed (Linum usitatissimum) supplementation on glycemic control and insulin resistance in prediabetes and type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. — PubMed PMID: 35843472
  7. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013). Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutrition Research. — PubMed PMID: 23684438
  8. Kristensen M, Jensen MG, Aarestrup J, et al. (2012). Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type. Nutrition & Metabolism. — PubMed PMID: 22305169
  9. Ibrügger S, Kristensen M, Mikkelsen MS, Astrup A (2012). Flaxseed dietary fiber supplements for suppression of appetite and food intake. Appetite. — PubMed PMID: 22245724
  10. Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A (2016). Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. International Journal of Food Sciences and Nutrition. — PubMed PMID: 26983396

Back to Table of Contents

Key Research Papers: Form, Processing and Safety

  1. Austria JA, Richard MN, Chahine MN, et al. (2008). Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. Journal of the American College of Nutrition. — PubMed PMID: 18689552
  2. Kuijsten A, Arts IC, van't Veer P, Hollman PC (2005). The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed. The Journal of Nutrition. — PubMed PMID: 16317125
  3. Nesbitt PD, Lam Y, Thompson LU (1999). Human metabolism of mammalian lignan precursors in raw and processed flaxseed. The American Journal of Clinical Nutrition. — PubMed PMID: 10075344
  4. Cunnane SC, Ganguli S, Menard C, et al. (1993). High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. The British Journal of Nutrition. — PubMed PMID: 8098222
  5. Abraham K, Buhrke T, Lampen A (2016). Bioavailability of cyanide after consumption of a single meal of foods containing high levels of cyanogenic glycosides: a crossover study in humans. Archives of Toxicology. — PubMed PMID: 25708890
  6. EFSA Panel on Contaminants in the Food Chain (2019). Evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels. EFSA Journal. — doi:10.2903/j.efsa.2019.5662
  7. Malcolmson LJ, Przybylski R, Daun JK (2000). Storage stability of milled flaxseed. Journal of the American Oil Chemists' Society. — doi:10.1007/s11746-000-0038-0
  8. Simon JA, Chen YH, Bent S (2009). The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. The American Journal of Clinical Nutrition. — PubMed PMID: 19321563
  9. Alonso L, Marcos ML, Blanco JG, et al. (1996). Anaphylaxis caused by linseed (flaxseed) intake. The Journal of Allergy and Clinical Immunology. — PubMed PMID: 8757228
  10. Parikh M, Maddaford TG, Austria JA, Aliani M, Netticadan T, Pierce GN (2019). Dietary Flaxseed as a Strategy for Improving Human Health. Nutrients. — PubMed PMID: 31130604

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents